Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -121% | $ -96.16M | $ 79.48M |
3/31/2025 | 2.39% | $ 4.11M | $ 172.22M |
12/31/2024 | 22.3% | $ 47.01M | $ 210.78M |
9/30/2024 | 26.85% | $ 57.78M | $ 215.23M |
6/30/2024 | 39.04% | $ 93.45M | $ 239.4M |
3/31/2024 | 14.57% | $ 23.73M | $ 162.87M |
12/31/2023 | -2.45% | $ -3.16M | $ 129.01M |
9/30/2023 | -38.6% | $ -33.65M | $ 87.17M |
6/30/2023 | -169.45% | $ -73.59M | $ 43.43M |
3/31/2023 | -320.18% | $ -80.88M | $ 25.26M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for ENTRADA THERAPEUTICS INC is calculated as follows: Op. Inc. [ $ -26.67M ] / Revenues [ $ 0 ]
(=) Operating % [ 0% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |